NCT06744361View on ClinicalTrials.gov

Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest

PHASE2RecruitingINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

December 12, 2024

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2027

Conditions
Out-of-hospital Cardiac Arrest (OHCA)
Interventions
DRUG

esketamine hydrochloride

Prehospital intravenous or intraosseous bolus administration at a minimum of 0.5 mg/kg of esketamine

DRUG

propofol

Prehospital intravenous or intraosseous bolus administration at a minimum dose of 0.25 mg/kg propofol

Trial Locations (2)

2100

RECRUITING

Department of Cardiology, Rigshospitalet, Copenhagen

5000

NOT_YET_RECRUITING

Odense University Hospital, Odense C

All Listed Sponsors
lead

Christian Hassager

OTHER